Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

EGM Statement

30 Jun 2008 12:12

RNS Number : 8010X
Vernalis PLC
30 June 2008
 



30 June 2008

VERNALIS PLC

RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 30 JUNE 2008

Vernalis plc announces that all resolutions proposed to shareholders at the Extraordinary General Meeting held earlier today were duly passed.

All resolutions were approved on a show of hands. The number of proxy votes received for each resolution is set out below.

Resolution

For (including discretionary votes)*

Against*

Withheld

Ordinary Resolution

1. To approve the sale by the Company of Apokyn® and the US Commercial Operations

143,094,025

(99.98%)

25,322

(0.02%)

7,576

2. To increase the Company's authorised share capital and to authorise the Directors to allot relevant securities 

143,060,249

(99.98%)

28,285

(0.02%)

38,389

Special Resolution

3. To authorise the Directors to allot equity securities for cash without application of statutory pre-emption rights

142,665,007

(99.72%)

403,407

(0.28%)

58,509

*NB: Percentage of votes cast excludes withheld votes

Vernalis has forwarded to the Document Viewing Facility of the Financial Services Authority two copies of the resolutions passed at the Extraordinary General Meeting. These copies will shortly be available for viewing at the Document Facility, at the address below, from 9.00am to 5.30pm on every weekday except bank holidays.

Document Viewing Facility

The Financial Services Authority

25 The North ColonadeCanary Wharf

London E14 5HS

Tel: 020 7066 1000

Printed copies of the resolutions may be obtained by writing to The Company Secretary, Vernalis plc, Oakdene Court, 613 reading Road, Winnersh, Berkshire RG41 5UA.

Enquiries:

Vernalis plc +44 (0)118 977 3133

Tony Weir, Chief Financial Officer

Brunswick Group +44 (0)20 7404 5959

Jon Coles

Justine McIlroy

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EGMBDLLLVQBLBBQ
Date   Source Headline
5th Oct 20094:40 pmRNSSecond Price Monitoring Extn
5th Oct 20094:35 pmRNSPrice Monitoring Extension
22nd Sep 20094:35 pmRNSPrice Monitoring Extension
18th Sep 20094:40 pmRNSSecond Price Monitoring Extn
18th Sep 20094:35 pmRNSPrice Monitoring Extension
15th Sep 20097:00 amRNSRecruitment Completed in V3381 Phase II Study
9th Sep 20092:29 pmRNSHolding(s) in Company
24th Aug 20094:18 pmRNSHolding(s) in Company
24th Aug 20094:18 pmRNSHolding(s) in Company
21st Aug 20095:22 pmRNSHolding(s) in Company
20th Aug 20094:48 pmRNSAdmission of Subscription Shares to GSK
12th Aug 200911:59 amRNSHolding(s) in Company
11th Aug 20094:21 pmRNSHolding(s) in Company
11th Aug 20094:19 pmRNSHolding(s) in Company
6th Aug 20097:00 amRNSAnnouncement of Interim Results
6th Aug 20097:00 amRNSVernalis and GlaxoSmithKline enter collaboration
6th Aug 20097:00 amRNSInterest in shares in Vernalis plc
21st Jul 20097:00 amRNSNew Oncology Development Candidate Announced
16th Jul 20097:00 amRNSVernalis receives milestone payment from Novartis
8th Jul 200911:00 amRNSNotice of 2009 Half Year Results
25th Jun 20091:00 pmRNSResult of AGM
3rd Jun 20097:00 amRNSInterim Management Statement
2nd Jun 20094:54 pmRNSHolding(s) in Company
2nd Jun 20092:36 pmRNSApproval for Frovatriptan in Korea secured
1st Jun 20094:43 pmRNSDirector/PDMR Shareholding
29th May 20094:39 pmRNSDirector/PDMR Shareholding
28th May 20096:27 pmRNSAnnual Information Update
21st May 20094:09 pmRNSDirector/PDMR Shareholding-Amendment
21st May 20094:02 pmRNSHolding(s) in Company
21st May 20093:58 pmRNSAGM + Annual Report Notice
20th May 20094:11 pmRNSDirector/PDMR Shareholding
20th May 20093:14 pmRNSHolding(s) in Company
18th May 20091:00 pmRNSResult of General Meeting
18th May 20097:00 amRNSResults of Placing & Open Offer
13th May 20095:11 pmRNSDirector/PDMR Shareholding
7th May 20097:00 amRNSNew three-year Collaboration with Servier
30th Apr 20097:00 amRNSPublication of Prospectus
29th Apr 20094:00 pmRNSAnnual Financial Report
29th Apr 20097:00 amRNSPlacing and Open Offer
29th Apr 20097:00 amRNSFinal Results
27th Mar 20097:00 amRNSPipeline update
29th Dec 200810:00 amRNSDirector/PDMR Shareholding
24th Dec 200812:00 pmRNSHolding(s) in Company
22nd Dec 20084:27 pmRNSHolding(s) in Company
15th Dec 20084:35 pmRNSPrice Monitoring Extension
19th Nov 20084:30 pmRNSDirector Directorships Declaration
14th Nov 20087:00 amRNSAppointment of new CEO and new CFO
14th Nov 20087:00 amRNSInterim Management Statement
13th Nov 20084:42 pmRNSSecond Price Monitoring Extn
13th Nov 20084:37 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.